| Year |
Citation |
Score |
| 2018 |
Rafiq S, Yeku OO, Jackson HJ, Purdon TJ, van Leeuwen DG, Drakes DJ, Song M, Miele MM, Li Z, Wang P, Yan S, Xiang J, Ma X, Seshan VE, Hendrickson RC, et al. Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo. Nature Biotechnology. PMID 30102295 DOI: 10.1038/Nbt.4195 |
0.302 |
|
| 2018 |
Ahmed M, Lopez-Albaitero A, Pankov D, Santich BH, Liu H, Yan S, Xiang J, Wang P, Hasan AN, Selvakumar A, O'Reilly RJ, Liu C, Cheung NV. TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies. Jci Insight. 3. PMID 29467338 DOI: 10.1172/Jci.Insight.97805 |
0.347 |
|
| 2017 |
Rao TD, Fernández-Tejada A, Axelrod A, Rosales N, Yan X, Thapi S, Wang A, Park KJ, Nemieboka B, Xiang J, Lewis JS, Olvera N, Levine DA, Danishefsky SJ, Spriggs D. Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth. Acs Chemical Biology. PMID 28617578 DOI: 10.1021/Acschembio.7B00305 |
0.322 |
|
| 2016 |
Liu H, Xu Y, Xiang J, Long L, Green S, Yang Z, Zimdahl B, Lu J, Cheng N, Horan LH, Liu B, Yan S, Wang P, Diaz J, Jin L, et al. Targeting alpha-fetoprotein (AFP)-MHC complex with CAR T cell therapy for liver cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27535982 DOI: 10.1158/1078-0432.Ccr-16-1203 |
0.306 |
|
| 2016 |
Dao T, Pankov D, Scott A, Korontsvit T, Zakhaleva V, Guerrerio MDdM, Xu Y, Xiang J, Yan S, Veomett N, Dubrovsky L, Curcio M, Doubrovina E, Liu C, O'Reilly RJ, et al. Abstract A055: Potent therapeutic and immunological effects of the first T-BiTE derived from a TCR-mimic antibody targeting intracellular oncoprotein WT1 Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-A055 |
0.334 |
|
| 2016 |
Liu H, Xu Y, Xiang J, Long L, Green S, Yang Z, Lu J, Cheng N, Horan LH, Liu B, Yan S, Wang P, Diaz J, Liu L, Chan V, et al. Abstract 2299: ET1402L1-CART, a T cell therapy targeting the intracellular tumor antigen AFP, demonstrates potent antitumor activity in hepatocellular carcinoma models Cancer Research. 76: 2299-2299. DOI: 10.1158/1538-7445.Am2016-2299 |
0.324 |
|
| 2015 |
Ataie N, Xiang J, Cheng N, Brea EJ, Lu W, Scheinberg DA, Liu C, Ng HL. Structure of a TCR mimic antibody with target predicts pharmacogenetics. Journal of Molecular Biology. PMID 26688548 DOI: 10.1016/J.Jmb.2015.12.002 |
0.319 |
|
| 2015 |
Dao T, Pankov D, Scott A, Korontsvit T, Zakhaleva V, Xu Y, Xiang J, Yan S, de Morais Guerreiro MD, Veomett N, Dubrovsky L, Curcio M, Doubrovina E, Ponomarev V, Liu C, et al. Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1. Nature Biotechnology. PMID 26389576 DOI: 10.1038/Nbt.3349 |
0.332 |
|
| 2015 |
Zhao Q, Hu J, Xiang J, Gu Y, Jin P, Hua F, Zhang Z, Liu Y, Zan K, Zhang Z, Zu J, Yang X, Shi H, Zhu J, Xu Y, et al. Intranasal administration of human umbilical cord mesenchymal stem cells-conditioned medium enhances vascular remodeling after stroke. Brain Research. 1624: 489-96. PMID 26279113 DOI: 10.1016/j.brainres.2015.08.003 |
0.386 |
|
| 2004 |
Xiang J, Jung JY, Sampson NS. Entropy effects on protein hinges: the reaction catalyzed by triosephosphate isomerase. Biochemistry. 43: 11436-45. PMID 15350130 DOI: 10.1021/Bi049208D |
0.536 |
|
| 2004 |
Xiang J, Sampson NS. Library screening studies to investigate substrate specificity in the reaction catalyzed by cholesterol oxidase. Protein Engineering, Design & Selection : Peds. 17: 341-8. PMID 15136716 DOI: 10.1093/Protein/Gzh041 |
0.533 |
|
| 2001 |
Xiang J, Sun J, Sampson NS. The importance of hinge sequence for loop function and catalytic activity in the reaction catalyzed by triosephosphate isomerase. Journal of Molecular Biology. 307: 1103-12. PMID 11286559 DOI: 10.1006/Jmbi.2001.4536 |
0.549 |
|
| Show low-probability matches. |